Sleepwalking and Zoloft: Discontinue or Reduce Sertraline and Consider Clonazepam
If a patient on Zoloft (sertraline) develops sleepwalking, the sertraline should be discontinued or dose-reduced, as SSRIs including sertraline are known to induce or exacerbate parasomnias including sleepwalking. 1 If sleepwalking persists after addressing the medication trigger, clonazepam 0.5-1 mg at bedtime is the most effective pharmacologic treatment, with a 90% response rate. 1
Understanding the Connection
SSRIs like sertraline are documented triggers for sleepwalking and other parasomnias. The evidence is clear from multiple guidelines that medications such as tricyclic antidepressants, MAOIs, and SSRIs have been shown to induce or exacerbate REM behavior disorder and other parasomnias 1. A systematic review specifically identified sertraline among antidepressants as a possible trigger for sleepwalking 2. The FDA label for Zoloft warns about "sleep-related behaviors including sleepwalking, eating, driving, and sexual behavior" as adverse effects 3.
Management Algorithm
Step 1: Assess the Clinical Situation
- Determine if sleepwalking began or worsened after starting sertraline
- Evaluate the severity and frequency of episodes
- Assess risk of injury to patient or bed partner
- Review if depression treatment can tolerate medication adjustment
Step 2: Address the Sertraline
Primary intervention:
- Discontinue sertraline if clinically feasible for the underlying depression
- Reduce the dose if discontinuation would compromise depression management
- Switch to an alternative antidepressant with lower parasomnia risk if continued antidepressant therapy is essential
The evidence shows that drug-induced parasomnias typically resolve with medication discontinuation or dose reduction 2, 4.
Step 3: Implement Environmental Safety Measures Immediately
While addressing the medication, protect the patient:
- Lower the bed mattress to floor level
- Pad sharp furniture corners
- Install window protection
- Remove potentially dangerous objects from the bedroom
- Remove all firearms, especially loaded handguns - these can be discharged during sleepwalking episodes 5
- Consider having bed partner sleep separately if violent episodes occur
Step 4: Evaluate for Underlying Sleep Disorders
Critical: Before attributing sleepwalking solely to sertraline, screen for:
- Obstructive sleep apnea (OSA) - frequently associated with chronic sleepwalking in adults 6
- Restless legs syndrome
- Periodic limb movements
- Upper airway resistance syndrome
If OSA is present, treatment with CPAP can eliminate sleepwalking entirely 6. One study showed all CPAP-compliant patients had complete control of sleepwalking, while those treated only with benzodiazepines had persistent symptoms 6.
Step 5: Pharmacologic Treatment if Needed
If sleepwalking persists after sertraline adjustment and treatment of any underlying sleep disorders:
First-line: Clonazepam 0.5-1 mg at bedtime 1, 5
- Effective in 90% of cases 1
- Can be taken 1-2 hours before bedtime if morning drowsiness occurs
- Benefits observed within the first week
- Little evidence of abuse in older patients
- Discontinuation usually results in symptom recurrence
Note: The irony here is that while sertraline can cause sleepwalking, there are isolated case reports of low-dose sertraline (25 mg) successfully treating sleep-related eating disorder 7. However, this does not apply to typical sleepwalking, and the weight of evidence supports SSRIs as triggers rather than treatments for sleepwalking.
Common Pitfalls to Avoid
Don't continue sertraline at the same dose hoping sleepwalking will spontaneously resolve - medication-induced parasomnias persist with continued exposure 2, 4
Don't treat with benzodiazepines alone without addressing the sertraline - patients treated only with benzodiazepines while continuing the triggering medication often have persistent symptoms 6
Don't miss underlying sleep apnea - treating OSA may completely resolve sleepwalking without need for additional medications 6
Don't underestimate injury risk - sleepwalking can involve violent behaviors and use of weapons; environmental safety is paramount 5
Don't assume all antidepressants carry equal risk - if continued antidepressant therapy is needed, consider alternatives with potentially lower parasomnia risk, though individual patient factors should guide selection 8
Special Considerations
For patients requiring continued antidepressant therapy: The choice of alternative should balance depression efficacy with parasomnia risk. While all SSRIs have been implicated in parasomnias 1, 2, switching to a different class or specific agent may be warranted based on individual patient factors.
Monitoring: After sertraline discontinuation or dose reduction, sleepwalking should improve within days to weeks. If symptoms persist beyond 2-4 weeks, polysomnography should be considered to evaluate for underlying sleep disorders 6.